Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × Folfox protocol × Clear all

NCT06529718 2025-11-17

SEVILLA

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06919848 2025-04-09

Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms